Drug resistant infections

News

A worker cleans the exterior of a train coach that has been converted into a Covid-19 isolation ward.

Opinion | 16 September 2020

Could Covid-19 be fuelling drug resistance? by Gemma Buckland Merrett

An illustration of pills.

Opinion | 13 July 2020

A lifeline for antibiotic development by Jeremy Knox

More news

Our work

Wellcome’s partnership with the World Health Organization

Wellcome is working with the World Health Organization (WHO) to take on big challenges in global health.

Surveillance and Epidemiology of Drug-resistant Infections Consortium

The Surveillance and Epidemiology of Drug-resistant Infections Consortium (SEDRIC) brings together a range of international experts to share expertise and take action to tackle the gaps in drug-resistant infections surveillance and epidemiology.

Reports

Report 14 October 2019 Updated 14 July 2020

Reframing resistance

DownloadPDF 1.1MB

This report aims to guide experts, communicators and practitioners to communicate with impact, so that the public understands and supports action on drug-resistant infections.

Report 14 October 2019 Updated 14 July 2020

Reframing Resistance

[Summary] This report aims to help experts and practitioners to communicate with impact, so that the public understands and supports action on drug-resistant infections.

Report 8 March 2019 Updated 4 December 2019

Call to Action on Antimicrobial Resistance 2018 Report

DownloadPDF 1.4MB

Key outcomes from the second Call to Action on Antimicrobial Resistance held in Ghana, co-hosted by the Governments of Ghana, Thailand and the UK, along with the World Bank, UN Foundation and Wellcome.

More reports

Briefings and responses

Consultation response 1 September 2020 Updated 15 September 2020

Response to European Medicines Agencies Network Strategy to 2025

DownloadPDF 193KB

The European Medicines Agencies Network issued a draft strategy document in July 2020, setting out a proposed strategy to guide the work of the European Medicines Agency and Heads of Medicines Agencies for the period 2021-2025 . Wellcome responded to the AMR themeatic questions within this open cons

Consultation response 1 June 2020 Updated 18 June 2020

Response to the Open Consultation on the Terms of Reference of the Independent Panel for Evidence on Action Against Antimicrobial Resistance

DownloadPDF 108KB
Consultation response 1 November 2019 Updated 4 December 2019

Response to the Open Consultation on the Terms of Reference of the Global Leaders Group on Antimicrobial Resistance

DownloadPDF 507KB
More briefings and responses